查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1591992

原位雜合反應市場：按產品、技術、應用和最終用戶分類 - 2025-2030 年全球預測

In Situ Hybridization Market by Product (Consumables, Instruments, Software), Technology (Chromogenic In Situ Hybridization, Fluorescence In Situ Hybridization), Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年原位雜合反應市場價值為18.1億美元，預計到2024年將達到19.4億美元，複合年成長率為7.92%，預計到2030年將達到31億美元。

ISH 是一種實驗技術，使用標記的互補 DNA、RNA 或修飾的核酸鏈（探針）將特定的 DNA 或 RNA 序列定位到組織的一部分或截面。對 ISH 的需求源於其提供空間和時間基因表現見解的能力，這對於基礎研究、診斷和臨床應用至關重要，特別是對於識別特定的癌細胞類型和遺傳異常。 ISH 的應用涵蓋腫瘤學、病毒學、病理學和神經科學，最終用途為醫院、研究機構和診斷實驗室。根據市場洞察，分子診斷技術的進步、癌症盛行率的增加以及對個人化醫療的需求作為關鍵成長要素受到嚴重影響。新探針（例如 FISH 和 CISH 中使用的探針）的激增提高了 ISH 的準確性和可靠性，並為相關人員創造了機會。然而，挑戰仍然存在，例如設備高成本、對技術純熟勞工的需求以及手術時間長，這可能會阻礙市場成長。創新發展的關鍵領域包括自動化ISH平台和具有成本效益的探針的市場開拓，這將降低資源匱乏地區的進入障礙並導致市場擴張。此外，增強的多重檢測能力可同時檢測多個目標，這為增強 ISH 在個人化醫療中的效用提供了獨特的機會。 ISH 市場仍然競爭激烈且分散，其特點是老牌公司和新興企業公司都專注於擴大產品系列和策略聯盟。對公司的建議包括投資研發以提高檢測靈敏度、在傳統領域之外實現產品應用多樣化，以及形成策略聯盟以利用新興市場。透過產品創新和策略夥伴關係關係克服限制對於在這個不斷擴張的行業中抓住成長機會至關重要。

主要市場統計
基準年[2023] 18.1億美元
預測年份 [2024] 19.4億美元
預測年份 [2030] 31億美元
複合年成長率（%） 7.92%

市場動態：揭示快速發展的雜合反應市場的關鍵市場洞察

原位雜合反應市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 需要快速診斷技術的感染疾病爆發
    • 人們對分子診斷工具的興趣日益濃厚
    • IVD相關研發投入增加
  • 市場限制因素
    • 識別低 DNA 和 RNA 序列的局限性
  • 市場機會
    • 3D螢光雜合反應（FISH）技術迅速興起
    • ISH 技術開發的技術進步與策略投資
  • 市場挑戰
    • 對缺乏熟練專業人員提供適當診斷的擔憂

波特五力：駕馭雜合反應市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解原位雜合反應市場的外部影響

外部宏觀環境因素在塑造原位雜合反應市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助企業預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解原位雜合反應市場的競爭格局

原位雜合反應市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣雜合反應市場供應商績效評估

FPNV 定位矩陣是評估原位雜合反應市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了雜合反應市場的成功之路

原位雜合反應市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 感染疾病的傳播需要快速診斷技術
      • 人們對分子診斷工具的興趣日益濃厚
      • 增加體外診斷相關研發投資
    • 抑制因素
      • 識別低 DNA 和 RNA 序列的局限性
    • 機會
      • 3D螢光雜合反應(FISH) 技術的快速發展
      • 開發 ISH 技術的技術進步和策略投資
    • 任務
      • 對缺乏熟練專業人員做出適當診斷的擔憂
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章原位雜合反應市場：依產品

  • 消耗品
    • 配件
    • 試劑套件和試劑
    • 探測
  • 裝置
  • 軟體

第7章原位雜合反應市場：依技術分類

  • 顯色原位雜合反應
  • 螢光雜合反應
    • DNA螢光原位雜合反應
    • PNA螢光原位雜合反應
    • RNA螢光原位雜合反應

第8章原位雜合反應市場：依應用分類

  • 癌症診斷
  • 細胞學
  • 免疫學
  • 感染疾病診斷
  • 神經科學

第9章原位雜合反應市場：依最終用戶分類

  • 學術研究所
  • 合約調查機構
  • 醫院和診斷實驗室
  • 製藥和生物技術公司

第10章美洲雜合反應市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區雜合反應市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲原位雜合反應市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Biocare Medical 收購 Empire Genomics | 新聞
    • Resolve Biosciences 獲 7,100 萬美元 B 輪資金籌措
    • 丹納赫收購 Aldevron
    • PNI 被丹納赫生命科學平台收購
    • Bio-Techne 宣布商業發布新型 DNAscope 原位雜合反應檢測
    • Avacta 宣布與 ABCAM plc 簽署經銷協議 | Business Wire
    • FDA核准羅氏 Ventana ALK (D5F3) CDx 檢測用於肺癌治療
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Abcam Plc
  • Abnova Corporation
  • Advanced Cell Diagnostics, Inc.
  • Agilent Technologies, Inc.
  • Bio SB
  • Bio-Rad Laboratories, Inc.
  • Biocare Medical, LLC
  • BioCat GmbH
  • Bioevopeak Co., Ltd.|
  • BioGenex Laboratories
  • Biomers.net GmbH
  • BioView Ltd.
  • Cell Line Genetics, Inc.
  • CellCarta Biosciences Inc.
  • Charles River Laboratories International, Inc.
  • CiteAb Ltd.
  • Cole-Parmer Instrument Company, LLC.
  • Creative Bioarray
  • Creative Biolabs
  • Daicel Arbor Biosciences
  • DSS Imagetech Pvt. Ltd.
  • Emsurg Healthcare（India）Pvt. Limited
  • Enzo Life Sciences, Inc.
  • Excilone
  • F. Hoffmann-La Roche Ltd
  • Flogentec
  • GeneDetect.com Limited
  • Intertek Group PLC
  • KromaTiD Inc.
  • Leica Biosystems Nussloch GmbH
  • Merck KGaA
  • Molecular Instruments, Inc.
  • NeoGenomics Laboratories, Inc.
  • Okabe Bureau
  • Opgen
  • Oxford Gene Technology IP Limited
  • PerkinElmer Inc.
  • Qiagen NV
  • QIMA Life Sciences
  • Reveal Biosciences, Inc.
  • Ribocon GmbH
  • Spatial Genomics, Inc.
  • Stratech Scientific Ltd
  • Suraksha Diagnostic Private Limited
  • Thermo Fisher Scientific Inc.
  • Vector Laboratories, Inc.
  • Zytomed Systems GmbH
  • ZytoVision GmbH
Product Code: MRR-49105D732D8B

The In Situ Hybridization Market was valued at USD 1.81 billion in 2023, expected to reach USD 1.94 billion in 2024, and is projected to grow at a CAGR of 7.92%, to USD 3.10 billion by 2030.

In situ hybridization (ISH) is a laboratory technique that uses a labeled complementary DNA, RNA, or modified nucleic acid strand (probe) to localize a specific DNA or RNA sequence in a portion or section of tissue. The necessity of ISH stems from its ability to provide spatial and temporal gene expression insight, which is crucial for basic research, diagnostics, and clinical applications, particularly in identifying specific types of cancer cells and genetic abnormalities. The application of ISH extends across oncology, virology, pathology, and neuroscience, with end-use spanning hospitals, research institutions, and diagnostic laboratories. Market insights reveal the significant influence of technological advancements in molecular diagnostics, increasing prevalence of cancer, and demand for personalized medicine as prime growth factors. The widespread adoption of novel probes, like those used in FISH and CISH, enhances the accuracy and reliability of ISH, presenting opportunities for stakeholders. However, challenges persist, including the high cost of instruments, need for skilled labor, and lengthy procedural times, which may hamper the market growth. Key areas for innovation include the development of automated ISH platforms and cost-effective probes, which lower the barrier for adoption in low-resource settings, thereby expanding the market. Additionally, enhancing multiplexing capabilities to simultaneously detect multiple targets presents a unique opportunity to bolster the utility of ISH in personalized medicine. The nature of the ISH market remains highly competitive and fragmented, characterized by a mix of established and emerging players focusing on expanding product portfolios and strategic collaborations. Recommendations for businesses include investing in R&D to improve assay sensitivity, diversifying product applications beyond traditional fields, and forming strategic alliances to capitalize on emerging markets. Overcoming limitations through product innovation and strategic partnerships will be central to capturing growth opportunities within this expanding field.

KEY MARKET STATISTICS
Base Year [2023] USD 1.81 billion
Estimated Year [2024] USD 1.94 billion
Forecast Year [2030] USD 3.10 billion
CAGR (%) 7.92%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving In Situ Hybridization Market

The In Situ Hybridization Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of infectious diseases demanding rapid diagnostic techniques
    • Rising inclination towards molecular diagnostic tools
    • Increasing investments in R&D pertaining to IVD
  • Market Restraints
    • Limitation in identifying the low DNA and RNA sequencing
  • Market Opportunities
    • Rapid advent of 3D fluorescence in situ hybridization (FISH) technologies
    • Technological advancements and strategic investments to develop ISH technologies
  • Market Challenges
    • Concerns regarding lack of skilled professionals to provide proper diagnosis

Porter's Five Forces: A Strategic Tool for Navigating the In Situ Hybridization Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the In Situ Hybridization Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the In Situ Hybridization Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the In Situ Hybridization Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the In Situ Hybridization Market

A detailed market share analysis in the In Situ Hybridization Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the In Situ Hybridization Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the In Situ Hybridization Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the In Situ Hybridization Market

A strategic analysis of the In Situ Hybridization Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the In Situ Hybridization Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abcam Plc, Abnova Corporation, Advanced Cell Diagnostics, Inc., Agilent Technologies, Inc., Bio SB, Bio-Rad Laboratories, Inc., Biocare Medical, LLC, BioCat GmbH, Bioevopeak Co., Ltd. |, BioGenex Laboratories, Biomers.net GmbH, BioView Ltd., Cell Line Genetics, Inc., CellCarta Biosciences Inc., Charles River Laboratories International, Inc., CiteAb Ltd., Cole-Parmer Instrument Company, LLC., Creative Bioarray, Creative Biolabs, Daicel Arbor Biosciences, DSS Imagetech Pvt. Ltd., Emsurg Healthcare (India) Pvt. Limited, Enzo Life Sciences, Inc., Excilone, F. Hoffmann-La Roche Ltd, Flogentec, GeneDetect.com Limited, Intertek Group PLC, KromaTiD Inc., Leica Biosystems Nussloch GmbH, Merck KGaA, Molecular Instruments, Inc., NeoGenomics Laboratories, Inc., Okabe Bureau, Opgen, Oxford Gene Technology IP Limited, PerkinElmer Inc., Qiagen N.V., QIMA Life Sciences, Reveal Biosciences, Inc., Ribocon GmbH, Spatial Genomics, Inc., Stratech Scientific Ltd, Suraksha Diagnostic Private Limited, Thermo Fisher Scientific Inc., Vector Laboratories, Inc., Zytomed Systems GmbH, and ZytoVision GmbH.

Market Segmentation & Coverage

This research report categorizes the In Situ Hybridization Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Consumables, Instruments, and Software. The Consumables is further studied across Accessories, Kits & Reagents, and Probes.
  • Based on Technology, market is studied across Chromogenic In Situ Hybridization and Fluorescence In Situ Hybridization. The Fluorescence In Situ Hybridization is further studied across DNA Fluorescence In Situ Hybridization, PNA Fluorescence In Situ Hybridization, and RNA Fluorescence In Situ Hybridization.
  • Based on Application, market is studied across Cancer Diagnostics, Cytology, Immunology, Infectious Disease Diagnostics, and Neuroscience.
  • Based on End User, market is studied across Academic & Research Institutes, Contract Research Organizations, Hospital & Diagnostic Laboratories, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of infectious diseases demanding rapid diagnostic techniques
      • 5.1.1.2. Rising inclination towards molecular diagnostic tools
      • 5.1.1.3. Increasing investments in R&D pertaining to IVD
    • 5.1.2. Restraints
      • 5.1.2.1. Limitation in identifying the low DNA and RNA sequencing
    • 5.1.3. Opportunities
      • 5.1.3.1. Rapid advent of 3D fluorescence in situ hybridization (FISH) technologies
      • 5.1.3.2. Technological advancements and strategic investments to develop ISH technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns regarding lack of skilled professionals to provide proper diagnosis
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. In Situ Hybridization Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
    • 6.2.1. Accessories
    • 6.2.2. Kits & Reagents
    • 6.2.3. Probes
  • 6.3. Instruments
  • 6.4. Software

7. In Situ Hybridization Market, by Technology

  • 7.1. Introduction
  • 7.2. Chromogenic In Situ Hybridization
  • 7.3. Fluorescence In Situ Hybridization
    • 7.3.1. DNA Fluorescence In Situ Hybridization
    • 7.3.2. PNA Fluorescence In Situ Hybridization
    • 7.3.3. RNA Fluorescence In Situ Hybridization

8. In Situ Hybridization Market, by Application

  • 8.1. Introduction
  • 8.2. Cancer Diagnostics
  • 8.3. Cytology
  • 8.4. Immunology
  • 8.5. Infectious Disease Diagnostics
  • 8.6. Neuroscience

9. In Situ Hybridization Market, by End User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Contract Research Organizations
  • 9.4. Hospital & Diagnostic Laboratories
  • 9.5. Pharmaceutical & Biotechnology Companies

10. Americas In Situ Hybridization Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific In Situ Hybridization Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa In Situ Hybridization Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Biocare Medical Acquires Empire Genomics | Precision Oncology News
    • 13.3.2. Resolve Biosciences Raises $71M in Series B Financing
    • 13.3.3. Danaher To Acquire Aldevron
    • 13.3.4. PNI to be Acquired by Danaher Corporation's Life Sciences Platform
    • 13.3.5. Bio-Techne has announced the commercial release of novel DNAscope in situ hybridization assays
    • 13.3.6. Avacta Announces Distribution Agreement With ABCAM plc | Business Wire
    • 13.3.7. FDA approves Roche's Ventana ALK (D5F3) CDx Assay for lung cancer
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Abcam Plc
  • 3. Abnova Corporation
  • 4. Advanced Cell Diagnostics, Inc.
  • 5. Agilent Technologies, Inc.
  • 6. Bio SB
  • 7. Bio-Rad Laboratories, Inc.
  • 8. Biocare Medical, LLC
  • 9. BioCat GmbH
  • 10. Bioevopeak Co., Ltd. |
  • 11. BioGenex Laboratories
  • 12. Biomers.net GmbH
  • 13. BioView Ltd.
  • 14. Cell Line Genetics, Inc.
  • 15. CellCarta Biosciences Inc.
  • 16. Charles River Laboratories International, Inc.
  • 17. CiteAb Ltd.
  • 18. Cole-Parmer Instrument Company, LLC.
  • 19. Creative Bioarray
  • 20. Creative Biolabs
  • 21. Daicel Arbor Biosciences
  • 22. DSS Imagetech Pvt. Ltd.
  • 23. Emsurg Healthcare (India) Pvt. Limited
  • 24. Enzo Life Sciences, Inc.
  • 25. Excilone
  • 26. F. Hoffmann-La Roche Ltd
  • 27. Flogentec
  • 28. GeneDetect.com Limited
  • 29. Intertek Group PLC
  • 30. KromaTiD Inc.
  • 31. Leica Biosystems Nussloch GmbH
  • 32. Merck KGaA
  • 33. Molecular Instruments, Inc.
  • 34. NeoGenomics Laboratories, Inc.
  • 35. Okabe Bureau
  • 36. Opgen
  • 37. Oxford Gene Technology IP Limited
  • 38. PerkinElmer Inc.
  • 39. Qiagen N.V.
  • 40. QIMA Life Sciences
  • 41. Reveal Biosciences, Inc.
  • 42. Ribocon GmbH
  • 43. Spatial Genomics, Inc.
  • 44. Stratech Scientific Ltd
  • 45. Suraksha Diagnostic Private Limited
  • 46. Thermo Fisher Scientific Inc.
  • 47. Vector Laboratories, Inc.
  • 48. Zytomed Systems GmbH
  • 49. ZytoVision GmbH

LIST OF FIGURES

  • FIGURE 1. IN SITU HYBRIDIZATION MARKET RESEARCH PROCESS
  • FIGURE 2. IN SITU HYBRIDIZATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS IN SITU HYBRIDIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS IN SITU HYBRIDIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC IN SITU HYBRIDIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC IN SITU HYBRIDIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. IN SITU HYBRIDIZATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. IN SITU HYBRIDIZATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. IN SITU HYBRIDIZATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. IN SITU HYBRIDIZATION MARKET DYNAMICS
  • TABLE 7. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY PROBES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY CHROMOGENIC IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY DNA FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY PNA FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY RNA FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY CYTOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY NEUROSCIENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY HOSPITAL & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS IN SITU HYBRIDIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC IN SITU HYBRIDIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 283. IN SITU HYBRIDIZATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 284. IN SITU HYBRIDIZATION MARKET, FPNV POSITIONING MATRIX, 2023